496 related articles for article (PubMed ID: 18728167)
1. Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I.
Meloni A; Furcas M; Cetani F; Marcocci C; Falorni A; Perniola R; Pura M; Bøe Wolff AS; Husebye ES; Lilic D; Ryan KR; Gennery AR; Cant AJ; Abinun M; Spickett GP; Arkwright PD; Denning D; Costigan C; Dominguez M; McConnell V; Willcox N; Meager A
J Clin Endocrinol Metab; 2008 Nov; 93(11):4389-97. PubMed ID: 18728167
[TBL] [Abstract][Full Text] [Related]
2. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1.
Meager A; Visvalingam K; Peterson P; Möll K; Murumägi A; Krohn K; Eskelin P; Perheentupa J; Husebye E; Kadota Y; Willcox N
PLoS Med; 2006 Jul; 3(7):e289. PubMed ID: 16784312
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene.
Wolff AS; Erichsen MM; Meager A; Magitta NF; Myhre AG; Bollerslev J; Fougner KJ; Lima K; Knappskog PM; Husebye ES
J Clin Endocrinol Metab; 2007 Feb; 92(2):595-603. PubMed ID: 17118990
[TBL] [Abstract][Full Text] [Related]
4. Assessment of autoantibodies to interferon-ω in patients with autoimmune polyendocrine syndrome type 1: using a new immunoprecipitation assay.
Larosa MDP; Mackenzie R; Burne P; Garelli S; Barollo S; Masiero S; Rubin B; Chen S; Furmaniak J; Betterle C; Smith BR
Clin Chem Lab Med; 2017 Jun; 55(7):1003-1012. PubMed ID: 28099118
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1).
Ströbel P; Murumägi A; Klein R; Luster M; Lahti M; Krohn K; Schalke B; Nix W; Gold R; Rieckmann P; Toyka K; Burek C; Rosenwald A; Müller-Hermelink HK; Pujoll-Borrell R; Meager A; Willcox N; Peterson P; Marx A
J Pathol; 2007 Apr; 211(5):563-571. PubMed ID: 17334980
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunoassay for autoantibodies against interferon omega; its use in the diagnosis of autoimmune polyendocrine syndrome type I.
Oftedal BE; Wolff AS; Bratland E; Kämpe O; Perheentupa J; Myhre AG; Meager A; Purushothaman R; Ten S; Husebye ES
Clin Immunol; 2008 Oct; 129(1):163-9. PubMed ID: 18708298
[TBL] [Abstract][Full Text] [Related]
7. Radioligand-binding assay reveals distinct autoantibody preferences for type I interferons in APS I and myasthenia gravis subgroups.
Hapnes L; Willcox N; Oftedal BE; Owe JF; Gilhus NE; Meager A; Husebye ES; Wolff AS
J Clin Immunol; 2012 Apr; 32(2):230-7. PubMed ID: 22127461
[TBL] [Abstract][Full Text] [Related]
8. Clinical and serologic parallels to APS-I in patients with thymomas and autoantigen transcripts in their tumors.
Wolff AS; Kärner J; Owe JF; Oftedal BE; Gilhus NE; Erichsen MM; Kämpe O; Meager A; Peterson P; Kisand K; Willcox N; Husebye ES
J Immunol; 2014 Oct; 193(8):3880-90. PubMed ID: 25230752
[TBL] [Abstract][Full Text] [Related]
9. Anti-cytokine autoantibodies preceding onset of autoimmune polyendocrine syndrome type I features in early childhood.
Wolff AS; Sarkadi AK; Maródi L; Kärner J; Orlova E; Oftedal BE; Kisand K; Oláh E; Meloni A; Myhre AG; Husebye ES; Motaghedi R; Perheentupa J; Peterson P; Willcox N; Meager A
J Clin Immunol; 2013 Nov; 33(8):1341-8. PubMed ID: 24158785
[TBL] [Abstract][Full Text] [Related]
10. A novel cell-based assay for measuring neutralizing autoantibodies against type I interferons in patients with autoimmune polyendocrine syndrome type 1.
Breivik L; Oftedal BE; Bøe Wolff AS; Bratland E; Orlova EM; Husebye ES
Clin Immunol; 2014 Jul; 153(1):220-7. PubMed ID: 24792136
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune polyendocrine syndrome type 1: an Italian survey on 158 patients.
Garelli S; Dalla Costa M; Sabbadin C; Barollo S; Rubin B; Scarpa R; Masiero S; Fierabracci A; Bizzarri C; Crinò A; Cappa M; Valenzise M; Meloni A; De Bellis AM; Giordano C; Presotto F; Perniola R; Capalbo D; Salerno MC; Stigliano A; Radetti G; Camozzi V; Greggio NA; Bogazzi F; Chiodini I; Pagotto U; Black SK; Chen S; Rees Smith B; Furmaniak J; Weber G; Pigliaru F; De Sanctis L; Scaroni C; Betterle C
J Endocrinol Invest; 2021 Nov; 44(11):2493-2510. PubMed ID: 34003463
[TBL] [Abstract][Full Text] [Related]
12. Novel sequence variation of AIRE and detection of interferon-omega antibodies in early infancy.
Tóth B; Wolff AS; Halász Z; Tar A; Szüts P; Ilyés I; Erdos M; Szegedi G; Husebye ES; Zeher M; Maródi L
Clin Endocrinol (Oxf); 2010 May; 72(5):641-7. PubMed ID: 19863576
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients.
Meloni A; Willcox N; Meager A; Atzeni M; Wolff AS; Husebye ES; Furcas M; Rosatelli MC; Cao A; Congia M
J Clin Endocrinol Metab; 2012 Apr; 97(4):1114-24. PubMed ID: 22344197
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune associations and autoantibody screening show focused recognition in patient subgroups with generalized myasthenia gravis.
Klein R; Marx A; Ströbel P; Schalke B; Nix W; Willcox N
Hum Immunol; 2013 Sep; 74(9):1184-93. PubMed ID: 23792059
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune polyendocrine syndrome type I in Slovakia: relevance of screening patients with autoimmune Addison's disease.
F Magitta N; Pura M; S Bøe Wolff A; Vanuga P; Meager A; M Knappskog P; Husebye ES
Eur J Endocrinol; 2008 May; 158(5):705-9. PubMed ID: 18426830
[TBL] [Abstract][Full Text] [Related]
16. Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1.
Meisel C; Akbil B; Meyer T; Lankes E; Corman VM; Staudacher O; Unterwalder N; Kölsch U; Drosten C; Mall MA; Kallinich T; Schnabel D; Goffinet C; von Bernuth H
J Clin Invest; 2021 Jul; 131(14):. PubMed ID: 34061776
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED)--a diagnostic and therapeutic challenge.
Jääskeläinen J; Perheentupa J
Pediatr Endocrinol Rev; 2009 Dec; 7(2):15-28. PubMed ID: 20118890
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune polyglandular syndrome type 1 in Russian patients: clinical variants and autoimmune regulator mutations.
Orlova EM; Bukina AM; Kuznetsova ES; Kareva MA; Zakharova EU; Peterkova VA; Dedov II
Horm Res Paediatr; 2010; 73(6):449-57. PubMed ID: 20407228
[TBL] [Abstract][Full Text] [Related]
19. The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1.
Oikonomou V; Smith G; Constantine GM; Schmitt MM; Ferré EMN; Alejo JC; Riley D; Kumar D; Dos Santos Dias L; Pechacek J; Hadjiyannis Y; Webb T; Seifert BA; Ghosh R; Walkiewicz M; Martin D; Besnard M; Snarr BD; Deljookorani S; Lee CR; DiMaggio T; Barber P; Rosen LB; Cheng A; Rastegar A; de Jesus AA; Stoddard J; Kuehn HS; Break TJ; Kong HH; Castelo-Soccio L; Colton B; Warner BM; Kleiner DE; Quezado MM; Davis JL; Fennelly KP; Olivier KN; Rosenzweig SD; Suffredini AF; Anderson MS; Swidergall M; Guillonneau C; Notarangelo LD; Goldbach-Mansky R; Neth O; Monserrat-Garcia MT; Valverde-Fernandez J; Lucena JM; Gomez-Gila AL; Garcia Rojas A; Seppänen MRJ; Lohi J; Hero M; Laakso S; Klemetti P; Lundberg V; Ekwall O; Olbrich P; Winer KK; Afzali B; Moutsopoulos NM; Holland SM; Heller T; Pittaluga S; Lionakis MS
N Engl J Med; 2024 May; 390(20):1873-1884. PubMed ID: 38810185
[TBL] [Abstract][Full Text] [Related]
20. Expanding the Phenotypic and Genotypic Landscape of Autoimmune Polyendocrine Syndrome Type 1.
Orlova EM; Sozaeva LS; Kareva MA; Oftedal BE; Wolff ASB; Breivik L; Zakharova EY; Ivanova ON; Kämpe O; Dedov II; Knappskog PM; Peterkova VA; Husebye ES
J Clin Endocrinol Metab; 2017 Sep; 102(9):3546-3556. PubMed ID: 28911151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
